Ennogen secures £30m credit facility to fuel expansion
UK-based pharma manufacturer Ennogen has received a £30 million credit facility from Santander UK to support its international growth strategy.
UK-based pharma manufacturer Ennogen has received a £30 million credit facility from Santander UK to support its international growth strategy.
Glucagon-like peptide-1 (GLP-1) receptor agonists, such as Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro, have garnered a lot of attention in the pharma industry and beyond.
Adare Pharma Solutions, a tech driven CDMO specializing in oral dosage forms, has announced expansions of its high potency handling capabilities in the U.S. and Europe.